Clinical Trial Update: A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating how hepatic function influences the pharmacokinetics and safety of ASP1941; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• ASP1941

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Liver Disease | Phase 1 | Status: COMPLETED